Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer

Woenckhaus, Matthias and Bubendorf, Lukas and Dalquen, Peter and Foerster, Julia and Blaszyk, Hagen and Mirlacher, Martina and Soler, Markus and Dietmaier, Wolfgang and Sauter, Guido and Hartmann, Arndt and Wild, Peter J. (2007) Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer. JOURNAL OF CLINICAL PATHOLOGY, 60 (5). pp. 483-486. ISSN 0021-9746,

Full text not available from this repository. (Request a copy)

Abstract

Aim: To investigate whether nuclear and cytoplasmic Maspin expression is associated with distinct clinicopathological parameters and TP53 expression in a representative series of primary non-small cell lung cancer (NSCLC). Methods: Tissue microarrays (n = 487) were used to immunohistochemically analyse expression of Maspin and TP53. Cytoplasmic and nuclear expression of Maspin was scored on the basis of the percentage of positive tumour cells. Univariate analysis of clinicopathological variables potentially affecting tumour-specific survival was performed. Results: Immunohistochemical Maspin expression (nuclear and cytoplasmic) was informative in 72.3% (352/487) of cases. Cytoplasmic and nuclear Maspin immunoreactivity in >= 10% of tumour cells was detected in 37.8% (133/352) and 65.3% (230/352) of informative cases, respectively. Nuclear and cytoplasmic Maspin staining was observed more frequently in primary squamous cell carcinomas than in other lung cancer types. Only nuclear Maspin immunoreactivity was significantly associated with positive TP53 staining. Cytoplasmic or nuclear Maspin expression was not associated with tumour-specific survival. Conclusion: Maspin expression was found both in the nucleus and the cytoplasm of NSCLC, more frequently in squamous cell carcinomas. However, no association with tumour-specific survival could be demonstrated.

Item Type: Article
Uncontrolled Keywords: TUMOR-SUPPRESSOR GENE; PROGNOSTIC-SIGNIFICANCE; TISSUE MICROARRAYS; PROMOTER; SERPIN; METHYLATION; CARCINOMA; GRADE;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Pathologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 14 Dec 2020 06:44
Last Modified: 14 Dec 2020 06:44
URI: https://pred.uni-regensburg.de/id/eprint/32830

Actions (login required)

View Item View Item